Acinic cell carcinoma of parotid gland.

Acinic cell carcinoma (ACC) is a rare malignant tumor of the salivary glands that accounts for 6%-10% of all salivary gland malignancies. It has a propensity to considerably recur, metastasize to the lung or cervical lymph nodes. In addition, ACC can potentially be fatal.

A rare case of breast invasive cribriform carcinoma.

Although invasive ductal carcinoma accounts for 75% of all primary breast cancers diagnosed, there are other, more uncommon kinds, including invasive cribriform carcinoma (ICC). Invasive cribriform carcinoma has 2 subtypes: pure and mixed. Ultrasonography and magnetic resonance imaging are the best imaging methods for assessing the characteristics of breast ICC (MRI).

Advanced magnetic resonance imaging of mixed mucinous breast cancer: A case report.

Well-differentiated adenocarcinoma, a rare subtype of infiltrating ductal carcinoma, is a kind of mucinous cancer of the breast. It accounts for around 2% of all invasive breast cancers. The average age of presentation is 65-70 years, whereas women under the age of 35 account for 1% of cases.

Carcinosarcoma of uterus.

Uterine carcinosarcoma, which is categorized as high-grade endometrial cancer, is an uncommon kind of malignant gynecological neoplasms. Clinically, this tumor frequently affects menopausal women and the main symptom is abnormally postmenopausal vaginal bleeding. Surgery continues to be the main treatment for carcinosarcoma.

Giant breast cavernous hemangioma.

Although breast vascular tumors are exceedingly rare, the benign group's most common tumor, the hemangioma, is frequently found in lumpectomy or mastectomy tissues during histological analyses. The 3 types of hemangiomas are capillary, cavernous, and venous. The most typical kind of hemangioma is cavernous.

Pathogenic Variant Profile of Hereditary Cancer Syndromes in a Vietnamese Cohort.

Background: Hereditary cancer syndromes (HCS) are responsible for 5-10% of cancer cases. Genetic testing to identify pathogenic variants associated with cancer predisposition has not been routinely available in Vietnam. Consequently, the prevalence and genetic landscape of HCS remain unknown.

Response to a Combination of Full-Dose Osimertinib and Ceritinib in a Non-Small Cell Lung Cancer Patient with EML4-ALK Rearrangement and Epidermal Growth Factor Receptor Co-Mutation.

Lung cancer has been the leading cause of cancer-related deaths in both developed and developing countries, with most primary lung cancers being non-small cell lung carcinomas. Treatment for this condition is sometimes individualized. With developments in modern treatment and phase III clinical trial results, epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors (TKIs) and ALK-TKI have proven thier superior effectivity in comparison with the standard platinum-based doublet and are commonly approved as first-line indications in previously untreated advanced non-small cell lung cancer (NSCLC) patients with EGFR or ALK mutations.

Post-Blunt Traumatic Hemobilia From Pseudoaneurysm Successfully Treated With Embolization.

Hemobilia is an uncommon but serious complication of traumatic liver injury. Diagnosis can be difficult because the presentation of gastrointestinal (GI) bleeding may be minimal or massive, and its delay is quite variable, ranging from a few days to several months. Radiologic evaluation, including ultrasound, CT, endoscopic retrograde cholangiopancreatography, and angiography, can be used for the diagnosis.

Household Financial Burden and Poverty Impacts of Cancer Treatment in Vietnam.

Purpose: This paper aims to analyze the household financial burden and poverty impacts of cancer treatment in Vietnam.

Methods: Under the "ASEAN CosTs in ONcology" study design, three major specialized cancer hospitals were employed to assemble the Vietnamese data. Factors of socioeconomic, direct, and indirect costs of healthcare were collected prospectively through both individual interviews and hospital financial records.